Zymeworks Inc. (ZYME)
NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 5.17 |
| Open | 5.11 |
| Bid | 5.71 x 800 |
| Ask | 5.85 x 800 |
| Day's range | 5.12 - 6.06 |
| 52-week range | 4.56 - 39.41 |
| Volume | |
| Avg. volume | 1,747,696 |
| Market cap | 336.228M |
| Beta (5Y monthly) | 1.06 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -4.97 |
| Earnings date | 02 Aug 2022 - 08 Aug 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 26.09 |
- PR Newswire
ALL BLUE CAPITAL EXPANDS ITS LEADERSHIP TEAM TO SUPPORT PROPOSED ACQUISITION OF ZYMEWORKS INC.
All Blue Capital ("AB"), a global investment firm, today announced that Siddhartha Mukherjee, MD, Associate Professor of Medicine in the Division of Hematology/Oncology at Columbia University Medical Center in New York City, recently joined AB as Medical Advisor.
- Zacks
Zymeworks Inc. (ZYME) Reports Q1 Loss, Lags Revenue Estimates
Zymeworks Inc. (ZYME) delivered earnings and revenue surprises of -22.68% and 49.07%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
- Business Wire
Zymeworks Provides Corporate Update and Reports First Quarter 2022 Financial Results
VANCOUVER, British Columbia, May 04, 2022--Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, today reported financial results for the first quarter ended March 31, 2022.
© 2022 Yahoo. All rights reserved.
